Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autoimmune hepatitis and its variant syndromes.

Literature DB >> 11559660

Autoimmune hepatitis and its variant syndromes.

Z Ben-Ari¹, A J Czaja.

Abstract

Entities: Disease

Mesh：

Substances：
HLA Antigens

Year: 2001 PMID： 11559660 PMCID： PMC1728469 DOI： 10.1136/gut.49.4.589

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

147 in total

1. Autoimmune hepatitis in childhood: a 20-year experience.

Authors: G V Gregorio; B Portmann; F Reid; P T Donaldson; D G Doherty; M McCartney; A P Mowat; D Vergani; G Mieli-Vergani
Journal: Hepatology Date: 1997-03 Impact factor: 17.425

2. Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C.

Authors: S Vento; F Cainelli; E Concia; T Ferraro
Journal: J Hepatol Date: 1997-04 Impact factor: 25.083

3. Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment.

Authors: A Tran; S Benzaken; G Yang; S Schneider; A Doglio; A Rampal; P Rampal
Journal: Dig Dis Sci Date: 1997-04 Impact factor: 3.199

4. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.

Authors: P Invernizzi; A Crosignani; P M Battezzati; G Covini; G De Valle; A Larghi; M Zuin; M Podda
Journal: Hepatology Date: 1997-05 Impact factor: 17.425

5. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.

Authors: M G Clemente; P Obermayer-Straub; A Meloni; C P Strassburg; V Arangino; R H Tukey; S De Virgiliis; M P Manns
Journal: J Clin Endocrinol Metab Date: 1997-05 Impact factor: 5.958

6. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.

Authors: P T Donaldson; D G Doherty; K M Hayllar; I G McFarlane; P J Johnson; R Williams
Journal: Hepatology Date: 1991-04 Impact factor: 17.425

7. Clonal accumulation of V beta 5.1-positive cells in the liver of a patient with autoimmune cholangiopathy.

Authors: Y Shimizu; K Higuchi; Y Kashii; M Miyamoto; T Tsukishiro; A Watanabe
Journal: Liver Date: 1997-02

Review 8. Extrahepatic immunologic features of chronic viral hepatitis.

Authors: A J Czaja
Journal: Dig Dis Date: 1997 May-Jun Impact factor: 2.404

9. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

Authors: M P Manns; K J Griffin; K F Sullivan; E F Johnson
Journal: J Clin Invest Date: 1991-10 Impact factor: 14.808

10. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.

Authors: A J Czaja; J Rakela; J E Hay; S B Moore
Journal: Gastroenterology Date: 1990-06 Impact factor: 22.682

17 in total

1. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory.

Authors: J Kwok; B Jones
Journal: J Clin Pathol Date: 2005-05 Impact factor: 3.411

Review 2. Autoimmune hepatitis: diagnosis, treatment, and prognosis.

Authors: Bruce A Luxon
Journal: Curr Gastroenterol Rep Date: 2006-02

3. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors: Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal: Gut Date: 2018-03-28 Impact factor: 23.059

Autoimmune hepatitis and its variant syndromes.

1. Autoimmune hepatitis in childhood: a 20-year experience.

2. Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C.

3. Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment.

4. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.

5. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.

6. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.

7. Clonal accumulation of V beta 5.1-positive cells in the liver of a patient with autoimmune cholangiopathy.

Review 8. Extrahepatic immunologic features of chronic viral hepatitis.

9. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

10. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.

1. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory.

Review 2. Autoimmune hepatitis: diagnosis, treatment, and prognosis.

3. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

4. Performance parameters of the conventional serological markers for autoimmune hepatitis.

Review 5. Difficult treatment decisions in autoimmune hepatitis.

6. Comparing the simplified and international autoimmune hepatitis group criteria in primary sclerosing cholangitis.

Review 7. Diagnosis and management of the overlap syndromes of autoimmune hepatitis.

Review 8. The overlap syndromes of autoimmune hepatitis.

Review 9. Overlap syndromes among autoimmune liver diseases.

Review 10. Overlap syndromes of autoimmune hepatitis: what is known so far.